Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease

Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease

Bibliographic Details
Main Authors:	Maurizio eCapuozzo, Eduardo eNava, Stefania eCascone, Claudia eCinque, Roberta eMarra, Alessandro eOttaiano, Corinne eScognamiglio, Emilia ePalumbo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-03-01
Series:	Frontiers in Pharmacology
Subjects:	Rheumatoid arthritis psoriatic arthritis biological drugs appropriateness prescriptive control expenditure autoimmune deseases
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00031/full

Similar Items

Epidemiology and economic impact of celiac disease in the South Vesuvian area of Naples: a survey
by: Maurizio eCapuozzo, et al.
Published: (2013-06-01)

Nilotinib for the frontline treatment of chronic myeloid leukemia carrying the p230 transcript: dream or reality?
by: Maurizio eCapuozzo, et al.
Published: (2014-02-01)

The relationship between obesity, cardiometabolic disorders and disease activity in psoriatic arthritis patients: data from the Russian register
by: Yuliia L. Korsakova, et al.
Published: (2021-05-01)

Etanercept induces remission of polyarteritis nodosa: a case report
by: Maurizio eCapuozzo, et al.
Published: (2014-06-01)

The role of targeted synthetic drugs in the treatment of rheumatic diseases: focus on tofacitinib
by: D. E. Karateev, et al.
Published: (2020-03-01)

The Patient’s Perspective on Psoriatic Arthritis: What More Can Rheumatologists Do to Optimise Disease Management?
by: Pfizer
Published: (2017-08-01)

Thermal alterations in patients with inflammatory diseases: a comparison between psoriatic and rheumatoid arthritis
by: A. Capo, et al.
Published: (2018-12-01)

Psoriatic arthritis: imaging techniques
by: E. Lubrano, et al.
Published: (2012-06-01)

Psoriatic arthritis as a distinct disease entity
by: Leung Y, et al.
Published: (2007-01-01)

Axial Psoriatic Disease: Clinical and Imaging Assessment of an Underdiagnosed Condition
by: Ivan Giovannini, et al.
Published: (2021-06-01)

Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs
by: A. E. Karateev, et al.
Published: (2019-05-01)

REVISITING THE DIAGNOSIS OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS
by: E. S. Yakubovskaya
Published: (2016-02-01)

Telaprevir or Boceprevir for Hepatitis C treatment: a first survey of pharmacoutilization
by: Maurizio eCapuozzo, et al.
Published: (2013-09-01)

The prevalence of comorbid and concomitant diseases in psoriatic arthritis patients, data from Russian register
by: Yu. L. Korsakova, et al.
Published: (2021-07-01)

Metabolomics Studies in Psoriatic Disease: A Review
by: John Koussiouris, et al.
Published: (2021-06-01)

Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS – 2015 UPDATE
by: Elsa Vieira Sousa
Published: (2015-07-01)

Prevalence of psoriatic arthritis and comorbidities in patients with severe psoriasis: Data of a retrospective analysis of a hospital cohort
by: N. V. Batkaeva, et al.
Published: (2017-03-01)

Multiplicity of comorbidities in patients with severe psoriasis
by: N. V. Batkaeva, et al.
Published: (2018-04-01)

Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population
by: Cassia FF, et al.
Published: (2021-05-01)

Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis
by: A. M. Dadalova, et al.
Published: (2020-11-01)

Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs
by: E. Lubrano, et al.
Published: (2012-06-01)

THE DIAGNOSTIC VALUE OF CLINICAL EXAMINATION AND ULTRASOUND STUDY OF ENTHESES FOR EARLY DETECTION OF PSORIATIC AND RHEUMATOID ARTHRITIS: REMARC STUDY
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-12-01)

Cardiovascular risk in psoriatic arthritis
by: V V Badokin, et al.
Published: (2009-06-01)

CLINICAL HETEROGENEITY OF EARLY PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2016-12-01)

Immunopathogenetic mechanisms of action of ustekinumab, a new drug for the treatment of psoriatic arthritis and psoriasis
by: T. V. Korotaeva, et al.
Published: (2015-06-01)

Cardiovascular risk factors in psoriatic and rheumatoid arthritis
by: Andrey Petrovich Rebrov, et al.
Published: (2011-05-01)

A case of rheumatoid spondyloarthritis!
by: Sujatha N, et al.
Published: (2019-01-01)

Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)

Nervous system diseases comorbid to psoriasis
by: Fisun A.V., et al.
Published: (2016-06-01)

The use of subcutaneous methotrexate from various manufacturers in real clinical practice: a comparative study
by: D. E. Karateev, et al.
Published: (2019-11-01)

RESULTS OF USTEKINUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION ACCORDING TO THE DATA OF PSUMMIT 1 AND PSUMMIT 2
by: Yu. L. Korsakova, et al.
Published: (2015-04-01)

Targeted Therapies in Axial Psoriatic Arthritis
by: Alberto Floris, et al.
Published: (2021-06-01)

CLINICAL EXPERIENCE WITH USTEKINUMAB IN THE TREATMENT OF EARLY PSORIATIC ARTHRITIS USING TREAT-TO-TARGET STRATEGY
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis
by: D S Novikova, et al.
Published: (2009-06-01)

THE PATTERN OF CARDIOVASCULAR COMORBIDITY IN PATIENTS WITH SEVERE FORMS OF PSORIASIS: DATA OF RETROSPECTIVE ANALYSIS OF A HOSPITAL COHORT
by: N. V. Batkaeva, et al.
Published: (2017-10-01)

Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: Pooled results through week 52 of two phase III, randomised, placebo-controlled studies
by: Boehncke, W.-H, et al.
Published: (2022)

Consequences of bariatric surgery on outcomes in rheumatic diseases
by: Eric Lespessailles, et al.
Published: (2019-03-01)

Cannot write session to /tmp/vufind_sessions/sess_ctr74b33vob6j5kjlc7ilbcrj2